Rigel Reports Second Quarter 2026 Financial Results

Go back to Rigel Reports Second Quarter 2026 Financial Results
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 48.11 +1.02 (2.17%)
Previous Close $47.09    52 Week High $4.38 
Open $47.50    52 Week Low $1.88 
Day High $48.54    P/E N/A 
Day Low $47.23    EPS $-1.12 
Volume 53,855